Denali Therapeutics DNLI
NASDAQ DNLI
$18.82 -0.11 (-0.58%)
As of: Oct 21, 2026 · 1:42 PM EDT

Denali Therapeutics (DNLI) Intangibles (2026)

Updated

Denali Therapeutics' Intangibles was $35.25 million in Q2 2026, down 2.1% from the prior quarter.

Analysis

Denali Therapeutics (DNLI) Intangibles (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Intangibles (Qtr)
1 Eli Lilly 1,133.99 Bn 1,102.58 Bn 19.71 Bn 18.11 Bn
2 Johnson & Johnson 615.70 Bn 534.23 Bn 17.26 Bn 48.23 Bn
3 AbbVie 501.05 Bn 474.16 Bn 12.70 Bn 49.14 Bn
4 Merck 367.41 Bn 321.79 Bn 12.21 Bn 24.98 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 42.07 Bn
6 Astrazeneca 261.20 Bn 234.88 Bn 12.86 Bn 37.72 Bn
7 Amgen 235.55 Bn 190.95 Bn 7.24 Bn 20.49 Bn
8 Gilead Sciences 190.64 Bn 164.84 Bn 6.22 Bn 14.03 Bn
9 Pfizer 169.29 Bn 115.93 Bn 10.94 Bn 47.05 Bn
10 Denali Therapeutics 3.52 Bn 109.15 Mn 3.51 Mn 35.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 35.25 Mn
Mar 31, 2026 36.00 Mn
API Access

Denali Therapeutics Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=intangibles&ticker=DNLI&period=max&api_key=YOUR_API_KEY